EPO × 10 Vials

1,314,450.00

Sales Count 33 units

1000 in stock

Introducing Erythropoietin (EPO) in a 3000 IU concentration, a recombinant glycoprotein hormone widely studied in research related to erythropoiesis and oxygen transport. EPO plays a critical role in regulating red blood cell production by stimulating erythroid progenitor cells in the bone marrow. Due to its biological importance, EPO is a key focus in experimental studies on anemia, hypoxia, and tissue oxygenation.

Key Efficacy
Stimulates bone marrow hematopoiesis: Acts directly on erythrocyte precursor cells in the bone marrow, accelerating their proliferation and differentiation, and increasing the number of red blood cells.
Improves hypoxia: Enhances the blood’s oxygen-carrying and oxygen-supplying capacity, alleviating symptoms such as fatigue, weakness, dizziness, and shortness of breath caused by anemia or hypoxia.
Clinical Applications: Primarily used to treat anemia caused by chronic kidney disease, chemotherapy, or surgery. It can also help improve adaptation to high-altitude hypoxia (as directed by a physician).

Name: Erythropoietin (EPO) 3000 IU
Molecular Weight: ~30.4 kDa (glycosylated protein; may vary by expression system)
Purity Level: ≥99%
Amino Acid Sequence: [Human EPO consists of 165 amino acids; exact recombinant sequence may vary by production method]